Axcan Intermediate Holdings Inc. , which is backed by TPG, said Wednesday that it’s changing its name to Aptalis Pharma. The rebranding follows Axcan’s $583 million buy of Eurand earlier this year.
PRESS RELEASE
Axcan Intermediate Holdings Inc. announces that, as of today, it is changing its name to Aptalis Pharma.
